Sunshine Coast
Sunshine Coast
Sunshine Coast, Queensland, Australia9 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Recruiting | Phase 3 | 2026-10-07 | NCT03486873 | |
| NTI164 in Autism Spectrum Disorder | Chemically-Induced Disorders, autism, autism spectrum disorder, cannabis dependence, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder, substance-related disorder | Not yet recruiting | Phase 3 | 2026-09-30 | NCT07257939 | |
| A Platform Trial for Gram Negative Bloodstream Infections | Gram-negative Bacteremia | Recruiting | Not applicable | 2026-09-04 | NCT06537609 | |
| A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer | Adnexal Diseases, Carcinoma, Ovarian Epithelial, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, carcinoma, endocrine system disorder, epithelial neoplasm, fallopian tube cancer, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, peritoneum cancer | Recruiting | Phase 1 | 2026-04-07 | NCT04516447 | |
| Australasian Resuscitation In Sepsis Evaluation: FLUid or Vasopressors In Emergency Department Sepsis | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Active, not recruiting | Phase 3 | 2026-03-17 | NCT04569942 | |
| A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Phase 3 | 2026-02-27 | NCT06532006 | |
| NODE (groiN ultrasOunD cancEr) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Lymph Node Metastasis, Lymphatic Metastasis, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, female reproductive system disorder, female reproductive system neoplasm, neoplasm, vulva cancer, vulvar disease | Recruiting | Not applicable | 2026-02-20 | NCT06264167 | |
| A First-in-human Study of IBI354 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors | Locally Advanced Unresectable or Metastatic Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2025-03-20 | NCT05636215 | |
| The EXCEL Registry of Patients Requiring ECMO | Critical Illness, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute respiratory failure, cardiac arrest, cardiovascular disorder, heart disorder | Recruiting | Not stated | 2023-09-15 | NCT03793257 |